Probes and techniques used in active and the hypoxia-based dormant state of an antitubercular drug screening assay

“Tuberculosis Fact sheet N°104”. WHO. October 2015. Retrieved 11 February 2016. Sikri, 2013, The evolution of Mycobacterium tuberculosis dormancy models, Curr Sci, 105, 5 Palomino, 2007, Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colorimetric methods, Clin Microbiol Infect, 13, 754, 10.1111/j.1469-0691.2007.01698.x Boshoff, 2005, Tuberculosis – metabolism and respiration in the absence of growth, Nat Rev Microbiol, 3, 70, 10.1038/nrmicro1065 Lakshminarayana SB, Huat TB, Ho PC, Manjunatha UH, Dartois V, Dick T, Rao SP. Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents. J Antimicrob Chemother, 2015;70:857–67. Khan, 2008, Simple whole cell based high throughput screening protocol using Mycobacterium bovis BCG for inhibitors against dormant and active tubercle bacilli, J Microbiol Methods, 73, 62, 10.1016/j.mimet.2008.01.015 Wayne, 1996, An in vitro model for sequential study of shift down of Mycobacterium tuberculosis through two stages of nonreplicating persistence, Infect Immun, 64, 2062, 10.1128/iai.64.6.2062-2069.1996 Jenkins, 2012, Current concepts in laboratory testing to guide antimicrobial therapy, Mayo Clin Proc, 87, 290, 10.1016/j.mayocp.2012.01.007 Kim, 2005, Drug-susceptibility testing in tuberculosis: methods and reliability of results, Eur Respir J, 25, 564, 10.1183/09031936.05.00111304 Primm, 2007, Recent advances in methodologies for the discovery of antimycobacterial drugs, Curr Bioact Compd, 3, 10.2174/157340707781695550 Srivastava, 1997, Beta-Galactosidase reporter system in mycobacteria and its application inrapid antimycobacterial drug screening, Biochem Biophys Res Commun, 235, 602, 10.1006/bbrc.1997.6837 Rowland, 1999, Fluorescence-based detection of lacZ reporter gene expression in intact and viable bacteria including Mycobacterium species, FEMS Microbiol Lett, 179, 317, 10.1111/j.1574-6968.1999.tb08744.x Forbes, 2015, A high throughput screening assay for anti- mycobacterial small molecules based on adenylate kinase release as a reporter of cell lysis, PLoS ONE, 10, e0129234, 10.1371/journal.pone.0129234 Kaur, 2015, A high-throughput cidality screen for Mycobacterium tuberculosis, PLoS ONE, 10, e0117577, 10.1371/journal.pone.0117577 Rodrigues, 2007, Use of BACTEC 460 TB system in the diagnosis of tuberculosis, Indian J Med Microbiol, 25, 32, 10.1016/S0255-0857(21)02231-3 Heifets, 1985, Radiometric method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide in 7h12 broth, J Clin Microbiol, 21, 200, 10.1128/jcm.21.2.200-204.1985 Bueno, 2012, Antitubercular in vitro drug discovery: Tools for begin the search, 147 Collins, 1997, Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium, Antimicrob Agents Chemother, 41, 1004, 10.1128/AAC.41.5.1004 Taneja, 2007, Resazurin reduction assays for screening of antitubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis, J antimicrob chemother, 60, 288, 10.1093/jac/dkm207 Piccaro, 2015, Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosis, J Antibiot (Tokyo), 68, 711, 10.1038/ja.2015.52 Ali-Vehmas, 1991, Automation of the resazurin reduction test using fluorometry of microtitration trays, Zentralbl Veterinarmed B, 38, 358 Caviedes, 2002, Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis, J Clin Microbiol, 40, 1873, 10.1128/JCM.40.5.1873-1874.2002 Kansal, 1998, Change in colony morphology influences the virulence as well as the biochemical properties of the Mycobacterium avium complex, Microb Pathog, 25, 203, 10.1006/mpat.1998.0227 Singh, 2011, A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents, J Microbiol Methods, 84, 202, 10.1016/j.mimet.2010.11.013 Muttucumaru, 2004, Gene expression profile of Mycobacterium tuberculosis in a nonreplicating state, Tuberculosis (Edinb), 84, 239, 10.1016/j.tube.2003.12.006 Sarkar, 2012, Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors, J Biomol Screen, 17, 966, 10.1177/1087057112445485 Cooksey, 1993, A rapid method for screening antimicrobial agents for activities against a strain of mycobacterium tuberculosis expressing firefly luciferase, Antimicrob Agents Chemother, 37, 1348, 10.1128/AAC.37.6.1348 Roberts, 2005, Bacterial luciferase is naturally destabilized in Mycobacterium tuberculosis and can be used to monitor changes in gene expression, FEMS Microbiol Lett, 243, 243, 10.1016/j.femsle.2004.12.010 Andreu, 2012, Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence, J Antimicrob Chemother, 67, 404, 10.1093/jac/dkr472 Cho, 2007, Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis, Antimicrob Agents Chemother, 51, 1380, 10.1128/AAC.00055-06 Dhandayuthapani, 1995, Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages, Mol. Microbiol, 17, 901, 10.1111/j.1365-2958.1995.mmi_17050901.x Kremer, 1995, Green fluorescent protein as a new expression marker in mycobacteria, Mol Microbiol, 17, 913, 10.1111/j.1365-2958.1995.mmi_17050913.x Valdivia, 1996, Applications for green fluorescent protein (GFP) in the study of host-pathogen interactions, Gene, 173, 47, 10.1016/0378-1119(95)00706-7 Collins, 1998, Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium Tuberculosis, Antimicrob Agents Chemother, 42, 344, 10.1128/AAC.42.2.344 Srivastava, 1998, Green fluorescent protein as a reporter in rapid screening of antituberculosis compounds in vitro and in macrophages, Biochem Biophys Res Commun, 253, 431, 10.1006/bbrc.1998.9147 Changsen, 2003, Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter, Antimicrob Agents Chemother, 47, 3682, 10.1128/AAC.47.12.3682-3687.2003 Shaner, 2005, Guide to choosing fluorescent proteins, Nat Methods, 2, 905, 10.1038/nmeth819 Carroll P, Schreuder LJ, Muwanguzi-Karugaba J, Wiles S, Robertson BD, Ripoll J, et al. Sensitive detection of gene expression in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters, PLoS ONE, 5(3): 2010;e9823. Yeware, 2018, Novel red fluorescence protein-based microplate assay for drug screening against dormant Mycobacterium tuberculosis by using paraffin, Tuberculosis, 110, 15, 10.1016/j.tube.2018.02.008 Zelmer, 2012, A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging, J Antimicrob Chemother, 67, 1948, 10.1093/jac/dks161 Manning, 2017, A high content microscopy assay to determine drug activity against intracellular Mycobacterium tuberculosis, Methods, 127, 3, 10.1016/j.ymeth.2017.03.022 Yeware, 2019, A high content screening assay for identifying inhibitors against active and dormant state intracellular Mycobacterium tuberculosis, J Microbiol Methods, 164, 105687, 10.1016/j.mimet.2019.105687 Silva-Miranda, 2015, High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis, Antimicrob Agents Chemother, 59, 693, 10.1128/AAC.03705-14